Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Olmos

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
Journal of Oncology|September 23, 2020
BRCA Mutations in Prostate Cancer: Prognostic and Predictive ImplicationsCarlo Messina, Carlo Cattrini, Davide Soldato, et al.
American Journal of Clinical Oncology|March 23, 2011
Role of palliative chemotherapy in advanced epithelioid sarcomaRobin L Jones, Anastasia Constantinidou, David Olmos, et al.
Oncology|January 27, 2009
Clinical benefit of new targeted agents in phase I trials in patients with advanced colorectal cancerHendrik-Tobias Arkenau, Andre T Brunetto, Jorge Barriuso, et al.
Cancer Letters|December 17, 2016
MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomasEdoardo Missiaglia, Chris J Shepherd, Ewa Aladowicz, et al.
Cancers|October 7, 2020
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate CancerCarlo Cattrini, Davide Soldato, Alessandra Rubagotti, et al.
European Urology Oncology|August 22, 2025
A Deep Prostate-specific Antigen Response to Darolutamide plus Androgen Deprivation Therapy Is Associated with Better Clinical Outcomes in the Phase 3 ARANOTE Trial in Patients with Metastatic Hormone-sensitive Prostate CancerFred Saad, Alberto Briganti, Kunhi Parambath Haresh, et al.
Medicina Clinica|January 24, 2013
[Natural history of moderate-degree carotid stenosis in patients with peripheral artery disease]Sara Mercedes Morales-Gisbert, Ángel Plaza-Martínez, Vicente Andrés Sala-Almonacil, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2008
90-Days mortality rate in patients treated within the context of a phase-I trial: how should we identify patients who should not go on trial?Hendrik-Tobias Arkenau, David Olmos, Joo Ern Ang, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|May 8, 2026
Expert practical recommendations for optimising tumour and germline testing of homologous recombination repair gene mutations in metastatic prostate cancerPilar González-Peramato, Eugenia García-Fernández, Ana Jambrina, et al.
Leukemia & Lymphoma|August 8, 2014
Role of vascular endothelial growth factor C in classical Hodgkin lymphomaAntonio Rueda, David Olmos, Luis Vicioso, et al.
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Journal of Oncology|September 23, 2020
BRCA Mutations in Prostate Cancer: Prognostic and Predictive ImplicationsCarlo Messina, Carlo Cattrini, Davide Soldato, et al.
American Journal of Clinical Oncology|March 23, 2011
Role of palliative chemotherapy in advanced epithelioid sarcomaRobin L Jones, Anastasia Constantinidou, David Olmos, et al.
Oncology|January 27, 2009
Clinical benefit of new targeted agents in phase I trials in patients with advanced colorectal cancerHendrik-Tobias Arkenau, Andre T Brunetto, Jorge Barriuso, et al.
Cancer Letters|December 17, 2016
MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomasEdoardo Missiaglia, Chris J Shepherd, Ewa Aladowicz, et al.
Cancers|October 7, 2020
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate CancerCarlo Cattrini, Davide Soldato, Alessandra Rubagotti, et al.
European Urology Oncology|August 22, 2025
A Deep Prostate-specific Antigen Response to Darolutamide plus Androgen Deprivation Therapy Is Associated with Better Clinical Outcomes in the Phase 3 ARANOTE Trial in Patients with Metastatic Hormone-sensitive Prostate CancerFred Saad, Alberto Briganti, Kunhi Parambath Haresh, et al.
Medicina Clinica|January 24, 2013
[Natural history of moderate-degree carotid stenosis in patients with peripheral artery disease]Sara Mercedes Morales-Gisbert, Ángel Plaza-Martínez, Vicente Andrés Sala-Almonacil, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2008
90-Days mortality rate in patients treated within the context of a phase-I trial: how should we identify patients who should not go on trial?Hendrik-Tobias Arkenau, David Olmos, Joo Ern Ang, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|May 8, 2026
Expert practical recommendations for optimising tumour and germline testing of homologous recombination repair gene mutations in metastatic prostate cancerPilar González-Peramato, Eugenia García-Fernández, Ana Jambrina, et al.
Leukemia & Lymphoma|August 8, 2014
Role of vascular endothelial growth factor C in classical Hodgkin lymphomaAntonio Rueda, David Olmos, Luis Vicioso, et al.
Pageof 13